Covered recipient · General Payments record
ANGELA MICHELLE RAMSEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,249.41
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $433.26 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.82 | 16 |
| Lilly USA, LLC | $76.62 | 5 |
| Axsome Therapeutics, Inc. | $74.03 | 3 |
| Novo Nordisk AS | $52.26 | 3 |
| ITI, Inc. | $23.43 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.69 | 1 |
| Acerta Pharma LLC | $13.84 | 1 |
| GlaxoSmithKline, LLC. | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.29 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148743 | CMS |
| ABBVIE INC. | $8.40 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148745 | CMS |
| ABBVIE INC. | $10.11 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148747 | CMS |
| ABBVIE INC. | $8.00 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148749 | CMS |
| ABBVIE INC. | $10.99 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148751 | CMS |
| ABBVIE INC. | $2.99 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148753 | CMS |
| ABBVIE INC. | $8.65 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148755 | CMS |
| ABBVIE INC. | $12.27 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148757 | CMS |
| ABBVIE INC. | $17.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148759 | CMS |
| ABBVIE INC. | $16.09 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148761 | CMS |
| ABBVIE INC. | $14.92 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148763 | CMS |
| ABBVIE INC. | $7.50 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148765 | CMS |
| ABBVIE INC. | $9.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148767 | CMS |
| ABBVIE INC. | $14.36 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148769 | CMS |
| ABBVIE INC. | $6.70 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148771 | CMS |
| ABBVIE INC. | $5.20 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108148773 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.84 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105302015 | CMS |
| Axsome Therapeutics, Inc. | $23.55 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148335833 | CMS |
| Axsome Therapeutics, Inc. | $22.77 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148335835 | CMS |
| Axsome Therapeutics, Inc. | $27.71 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148335837 | CMS |
| GlaxoSmithKline, LLC. | $13.57 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116003611 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.43 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143598975 | CMS |
| Lilly USA, LLC | $17.04 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135502566 | CMS |
| Lilly USA, LLC | $16.94 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135512582 | CMS |
| Lilly USA, LLC | $13.19 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135528789 | CMS |
| Lilly USA, LLC | $13.22 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472869 | CMS |
| Lilly USA, LLC | $16.23 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135515388 | CMS |
| Novo Nordisk Inc | $20.13 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100640382 | CMS |
| Novo Nordisk Inc | $15.76 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100526761 | CMS |
| Novo Nordisk Inc | $16.37 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100533713 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.69 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144620337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.